News
Analysts have provided Elevance Health with 11 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $476.73, suggesting a potential 41.8% upside.
Analysts generally have a positive outlook for Elevance Health, with an ‘Outperform’ consensus rating and a decent potential ...
Despite rising costs in its health insurance plans, Elevance Health reported more than $2 billion in first quarter net income thanks to growth in enrollment.
Elevance Health executives sought to ease the minds of skittish investors on Wall Street Tuesday, saying that while medical costs in Medicare Advantage remain elevated—following with an ongoing ...
ELEVANCE HEALTH Hedge Fund Activity We have seen 642 institutional investors add shares of ELEVANCE HEALTH stock to their portfolio, and 934 decrease their positions in their most recent quarter.
An Elevance health plan is suing two Georgia providers and billing company HaloMd, accusing them of illegally gaming the arbitration system set up by the No Surprises Act to help payers and ...
U.S. health insurer Elevance Health spent less than expected on medical care in the first quarter and said on Tuesday that demand for healthcare services among older adults was inline with ...
By Dean Seal Elevance Health lowered its profit guidance but held tight on its adjusted earnings target for the year after higher yields and more members boosted first-quarter revenue.
The complaint alleged that CVS Health-unit Aetna, Elevance Health and Humana paid the kickbacks to brokers in exchange for enrollments into the insurers’ Medicare Advantage plans.
Despite elevated medical costs, Elevance Health managed to perform more or less in line with expectations in the first quarter of 2025, bringing in $2.2 billion in profit, a slight decrease from the ...
Shares of Elevance Health Inc. ELV rose 1.39% to $386.22 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to ...
Elevance Health projected it will beat its earnings guidance in the first quarter and said medical costs are in line with expectations, contrasting with UnitedHealth Group's disappointing first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results